Clinical Characteristics and Management of Four Cases of Visceral Leishmaniasis-Associated Hemophagocytic Lymphohistiocytosis. [PDF]
Tian M, Li J, Dai S, Ma L.
europepmc +1 more source
Complete Resolution of Cutaneous Leishmaniasis With a Novel Topical Combination Therapy: A Case Series. [PDF]
Haghshenas H +3 more
europepmc +1 more source
Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform. [PDF]
Singh-Phulgenda S +16 more
europepmc +1 more source
Evaluation of the Efficacy of Sodium Chloride Nanoparticles on the Vitality of Leishmania Major (in vitro). [PDF]
Abbas Marhoon I, Majid Al-Musawi M.
europepmc +1 more source
Epidemiological insights and clinical management of paediatric kala-azar in Shanxi Province (2014-2023): retrospective analysis of case characteristics and therapeutic strategies. [PDF]
Zhao J, Ullah I, Fan H, Li X.
europepmc +1 more source
Metallic Particles in Sodium Battery Anodes: A Review. [PDF]
Ruiz R, Pérez-Vicente C, Alcántara R.
europepmc +1 more source
Identification of CβS and ODC antimony resistance markers in anthroponotic cutaneous leishmaniasis field isolates by gene expression profiling. [PDF]
Zarrinkar F +9 more
europepmc +1 more source
Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis. [PDF]
Solomon M +6 more
europepmc +1 more source
Chronic ulceration as a late manifestation of tropical disease. [PDF]
Janocha-Litwin J +3 more
europepmc +1 more source
Progress in antileishmanial drugs: Mechanisms, challenges, and prospects. [PDF]
Zhang H +9 more
europepmc +1 more source

